We then determined the diagnostic ability of APOA4, MLH3, CLU and APOE to classify cervical cancer, CIN II + III and the normal control group by calculating receiver operating characteristics (ROC) curves, which showed that only APOE can detect CIN II + III (85.7 % sensitivity and 53.9 % specificity). This evidence concerns the gene APOE and cervical cancer.